The present invention relates to compounds of formula (I) wherein variable
groups are as defined within; pharmaceutically acceptable salts,
solvates, solvates of such salts and prodrugs thereof and their use as
ileal bile acid transport (IBAT) inhibitors for the treatment of
hyperlipidaemia. Processes for their manufacture and pharmaceutical
compositions containing them are also described. 1
